Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study)
NCT ID: NCT05058521
Last Updated: 2021-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27490 participants
OBSERVATIONAL
2018-06-01
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis
NCT02959801
Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism
NCT03802929
Venous Thromboembolism (VTE) Knowledge
NCT05548010
Ultrasound Assessment of Isolated Distal Deep Vein Thrombosis
NCT06596941
The Study of Percutaneous Mechanical Thrombectomy Treating Acute Deep Vein Thrombosis of Lower Extremities
NCT05356767
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients baseline characteristics were extracted from database. VTE risk assessment was conducted with either Caprini risk assessment model (surgical patients) or Padua prediction score (medical patients). The evaluation was started upon admission and regularly repeated depending on the patient's condition. The last evaluation was conducted before discharge. The D-dimer values during hospitalization were also collected.
The rate of in-hospital VTE, distributions of in-hospital VTE patients and the receiver operating characteristic curves were analyzed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
In-hospital VTE group
In-hospital VTE group includes patients who were with a hospital stay over 3 days and new-onset of VTE during their stay. Patients who presented for VTE were excluded.
No interventions assigned to this group
Negative group
Negative group includes patients who were with a hospital stay over 3 days and did not have a VTE during their hospital stay.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Inpatients with a hospital stay over 3 days
3. With or without new-onset of VTE during their stay
Exclusion Criteria
2. Patients who were admitted in emergency department
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tsinghua Chang Gung Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weiwei Wu, MD
Role: PRINCIPAL_INVESTIGATOR
Beijing Tsinghua Chang Gung Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tsinghua Chang Gung Hosipital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19242-4-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.